Drug development (and academic medicine): charting the course forward.

Area of Science:

• Pharmacology and Drug Discovery
• Translational Medicine
• Regulatory Science

Background:

• Drug development is a complex process driven by both scientific innovation and economic viability.
• Historical successes in drug development are increasingly threatened by mounting economic and regulatory pressures.
• The traditional pathway from drug discovery to clinical application requires reevaluation to overcome current challenges.

Discussion:

• Substantive changes are needed to revitalize the drug development pipeline.
• Integrating clinical pharmacology expertise across academia, industry, and regulatory agencies is essential.
• A collaborative approach can address the multifaceted challenges in bringing new therapies to patients.

Key Insights:

• Economic and regulatory factors significantly impact the pace and success of drug development.
• The current drug development model may not be sustainable without significant adaptation.
• Cross-sectoral collaboration is vital for fostering innovation and efficiency.

Outlook:

• Future drug development hinges on adapting to economic realities and regulatory landscapes.
• Reimagining the drug development process is necessary to ensure continued therapeutic advancements.
• Enhanced collaboration and input from all stakeholders will drive the next generation of medicines.